Matches in SemOpenAlex for { <https://semopenalex.org/work/W2292016251> ?p ?o ?g. }
- W2292016251 abstract "Targeted drug delivery is a promising strategy for improving tumor therapy. Folate receptor (FR) is an established ovarian cancer marker that is also frequently found to be overexpressed in other major epithelial tumors. Meanwhile, functional FR−β is expressed in myeloid leukemias and in inflammatory macrophages, including tumor-associated macrophages. FR based tumor targeted drug delivery has been a very active area of research and recent advancement of this technology towards clinical translation is highly significant. FR targeting can be achieved via anti-FR antibody or by folate conjugation, each with distinctive advantages and pitfalls. Several monoclonal antibodies directed against FR−α have been developed. In addition, a large number of imaging agents, drug molecules, and drug carriers have been conjugated to folate for targeting the FR, mostly for targeting FR−α found on the surface of epithelial tumor cells. Only recently, however, have FR-targeted agents moved into Phase III clinical trials, exemplified by the monoclonal antibody farletuzumab and the low molecular weight folate conjugates, folate-99mTc (EC20) and folate-desacetylvinblastinehydrazide (EC145), representing each of the two competing strategies for targeting the FR. This review will focus on the activities related to clinical translation of FR-targeted agents. The reader will gain a better understanding of the landscape of clinical translation of this exciting technology and key findings in the clinical trials. The anticipated approval of these agents and the ongoing clinical development of several other folate conjugates should usher in a new era of clinical translation and validation of FR-targeted imaging and therapeutic agents for tumor imaging and therapy." @default.
- W2292016251 created "2016-06-24" @default.
- W2292016251 creator A5028427087 @default.
- W2292016251 creator A5032975730 @default.
- W2292016251 creator A5040959124 @default.
- W2292016251 creator A5057588710 @default.
- W2292016251 creator A5058712185 @default.
- W2292016251 creator A5086087383 @default.
- W2292016251 date "2016-02-05" @default.
- W2292016251 modified "2023-09-27" @default.
- W2292016251 title "Folate receptor targeted drug delivery- from the bench to the bedside" @default.
- W2292016251 cites W108344161 @default.
- W2292016251 cites W1278072151 @default.
- W2292016251 cites W1492263135 @default.
- W2292016251 cites W1513967026 @default.
- W2292016251 cites W153411300 @default.
- W2292016251 cites W1560482245 @default.
- W2292016251 cites W1565425041 @default.
- W2292016251 cites W1890366598 @default.
- W2292016251 cites W1917375749 @default.
- W2292016251 cites W1964051517 @default.
- W2292016251 cites W1967738525 @default.
- W2292016251 cites W1968927766 @default.
- W2292016251 cites W1969861043 @default.
- W2292016251 cites W1972106205 @default.
- W2292016251 cites W1974882629 @default.
- W2292016251 cites W1976971356 @default.
- W2292016251 cites W1979745458 @default.
- W2292016251 cites W1980955569 @default.
- W2292016251 cites W1986058155 @default.
- W2292016251 cites W1988368614 @default.
- W2292016251 cites W1992819900 @default.
- W2292016251 cites W1993012864 @default.
- W2292016251 cites W1995967787 @default.
- W2292016251 cites W1995980440 @default.
- W2292016251 cites W1997060572 @default.
- W2292016251 cites W2000605631 @default.
- W2292016251 cites W2002978200 @default.
- W2292016251 cites W2008644522 @default.
- W2292016251 cites W2009193838 @default.
- W2292016251 cites W2009885156 @default.
- W2292016251 cites W2013261709 @default.
- W2292016251 cites W2019207861 @default.
- W2292016251 cites W2019287461 @default.
- W2292016251 cites W2020168409 @default.
- W2292016251 cites W2023298707 @default.
- W2292016251 cites W2039934078 @default.
- W2292016251 cites W2042118791 @default.
- W2292016251 cites W2042493999 @default.
- W2292016251 cites W2043179683 @default.
- W2292016251 cites W2051052717 @default.
- W2292016251 cites W2055954943 @default.
- W2292016251 cites W2058104225 @default.
- W2292016251 cites W2060459188 @default.
- W2292016251 cites W2060726255 @default.
- W2292016251 cites W2060882819 @default.
- W2292016251 cites W2064525881 @default.
- W2292016251 cites W2068715081 @default.
- W2292016251 cites W2078113421 @default.
- W2292016251 cites W2078886699 @default.
- W2292016251 cites W2083852274 @default.
- W2292016251 cites W2085016749 @default.
- W2292016251 cites W2085277047 @default.
- W2292016251 cites W2086615176 @default.
- W2292016251 cites W2094066635 @default.
- W2292016251 cites W2094599587 @default.
- W2292016251 cites W2095489734 @default.
- W2292016251 cites W2101515095 @default.
- W2292016251 cites W2105678378 @default.
- W2292016251 cites W2117500864 @default.
- W2292016251 cites W2120888343 @default.
- W2292016251 cites W2124979764 @default.
- W2292016251 cites W2133786616 @default.
- W2292016251 cites W2134039025 @default.
- W2292016251 cites W2137466593 @default.
- W2292016251 cites W2138036137 @default.
- W2292016251 cites W2139226114 @default.
- W2292016251 cites W2140853963 @default.
- W2292016251 cites W2142904352 @default.
- W2292016251 cites W2143417322 @default.
- W2292016251 cites W2148111285 @default.
- W2292016251 cites W2150451572 @default.
- W2292016251 cites W2162114522 @default.
- W2292016251 cites W2164288350 @default.
- W2292016251 cites W2165438610 @default.
- W2292016251 cites W2166500340 @default.
- W2292016251 cites W2168314897 @default.
- W2292016251 cites W2191037974 @default.
- W2292016251 cites W2192837054 @default.
- W2292016251 cites W2200218841 @default.
- W2292016251 cites W2200995144 @default.
- W2292016251 cites W2232720345 @default.
- W2292016251 cites W2234764081 @default.
- W2292016251 cites W2254792577 @default.
- W2292016251 cites W2287062696 @default.
- W2292016251 cites W2315917227 @default.
- W2292016251 cites W2328559027 @default.
- W2292016251 cites W2422451355 @default.
- W2292016251 cites W2428200563 @default.
- W2292016251 cites W2499932336 @default.